Ahmedabad, Gujarat, India Claris Lifesciences is the famous Corporate Investor, which was founded in 1994. The company was established in Asia in India. The main office of represented Corporate Investor is situated in the Ahmedabad.
The fund is generally included in less than 2 deals every year. The usual things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2008.
The usual cause for the fund is to invest in rounds with more than 10 partakers. Despite the Claris Lifesciences, startups are often financed by Wellington Partners, Sanderling Ventures, Index Ventures. The meaningful sponsors for the fund in investment in the same round are Scott Harkonen, Sanderling Ventures, Robin J. Cook.
Among the most popular portfolio startups of the fund, we may highlight CoMentis. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Health Care, Biotechnology. For fund there is no match between the location of its establishment and the land of its numerous investments - United States.
Related Funds
| Fund Name | Location |
| Breakthrough Energy Solutions Canada | Canada, Ontario, Toronto |
| Digital Entertainment Ventures (DEV) | New York, New York, United States |
| DSA Invest | Aachen, Germany, Nordrhein-Westfalen |
| Inova Personalized Health Accelerator | Fairfax, United States, Virginia |
| JIC Venture Growth Investments | Chiyoda, Japan |
| M3 Ventures | New York, New York, United States |
| New Form Capital | New York, New York, United States |
| Renegade Partners | California, San Francisco, United States |
| Transform VC | California, San Francisco, United States |
| Transmedia Capital | California, San Francisco, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 